[(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate

C32H36N10O4 — CID 56620933

IUPAC[(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate
SMILESCCc1nc([C@H]2O[C@@H](n3cnc4c(NCC(c5ccccc5)c5ccccc5)nc(N[C@@H]5CCNC5)nc43)[C@H](OC=O)[C@@H]2O)n[nH]1
InChIInChI=1S/C32H36N10O4/c1-2-23-37-29(41-40-23)26-25(44)27(45-18-43)31(46-26)42-17-35-24-28(38-32(39-30(24)42)36-21-13-14-33-15-21)34-16-22(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,17-18,21-22,25-27,31,33,44H,2,13-16H2,1H3,(H,37,40,41)(H2,34,36,38,39)/t21-,25-,26+,27-,31-/m1/s1
InChIKeyGKPCBXWJVVIJLN-MGNILDGKSA-N
MW624.71 g/mol
LogP2.70
Rot. Bonds12

About [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate

[(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate (PubChem CID 56620933) has the molecular formula C32H36N10O4 and a molecular weight of 624.71 g/mol. Its IUPAC name is [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate.

Molecular Properties

Compound Name[(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate
PubChem CID56620933
Molecular FormulaC32H36N10O4
Molecular Weight624.71 g/mol
Exact Mass624.29
IUPAC Name[(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate
SMILESCCc1nc([C@H]2O[C@@H](n3cnc4c(NCC(c5ccccc5)c5ccccc5)nc(N[C@@H]5CCNC5)nc43)[C@H](OC=O)[C@@H]2O)n[nH]1
InChIInChI=1S/C32H36N10O4/c1-2-23-37-29(41-40-23)26-25(44)27(45-18-43)31(46-26)42-17-35-24-28(38-32(39-30(24)42)36-21-13-14-33-15-21)34-16-22(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,17-18,21-22,25-27,31,33,44H,2,13-16H2,1H3,(H,37,40,41)(H2,34,36,38,39)/t21-,25-,26+,27-,31-/m1/s1
InChIKeyGKPCBXWJVVIJLN-MGNILDGKSA-N
XLogP2.70
TPSA177.02 Ų
H-Bond Donors5
H-Bond Acceptors13
Rotatable Bonds12
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500624.71
LogP ≤ 52.70
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate?
The IUPAC name of [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate (CID 56620933) is [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate.
What is the SMILES notation for [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate?
The canonical SMILES for [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate is CCc1nc([C@H]2O[C@@H](n3cnc4c(NCC(c5ccccc5)c5ccccc5)nc(N[C@@H]5CCNC5)nc43)[C@H](OC=O)[C@@H]2O)n[nH]1.
What is the InChIKey of [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate?
The InChIKey is GKPCBXWJVVIJLN-MGNILDGKSA-N. The full InChI is InChI=1S/C32H36N10O4/c1-2-23-37-29(41-40-23)26-25(44)27(45-18-43)31(46-26)42-17-35-24-28(38-32(39-30(24)42)36-21-13-14-33-15-21)34-16-22(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,17-18,21-22,25-27,31,33,44H,2,13-16H2,1H3,(H,37,40,41)(H2,34,36,38,39)/t21-,25-,26+,27-,31-/m1/s1.
What are the key properties of [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate?
[(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate has a molecular weight of 624.71 g/mol, XLogP of 2.70, 12 rotatable bonds, 5 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5R)-2-[6-(2,2-diphenylethylamino)-2-[[(3R)-pyrrolidin-3-yl]amino]purin-9-yl]-5-(5-ethyl-1H-1,2,4-triazol-3-yl)-4-hydroxyoxolan-3-yl] formate is sourced from PubChem (CID 56620933), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).